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ABSTRACT

Blum, Kevin M. M.S.B.M.E., Purdue University, May 2015. High Density Collagen
Fibril Constructs With Tunable Mechano-Biology in Acellular and Cellular
Configurations. Major Professor: Sherry Voytik-Harbin.
Collagen has long been used as a material for tissue engineering due to its prevalence
in the extracellular matrix of connective tissues. However, traditional collagen materials
utilizing atelocollagen and acid solubilized telocollagen have lacked the mechanical
integrity and collagen fibril density found in the in vivo state. Here, we utilize collagen
oligomers and confined compression to forcibly remove a portion of the fluid phase
component. Materials were created with controlled, substantially increased material
properties, including order of magnitude increases in collagen fibril density, elastic
modulus, compressive modulus,and resistance to proteolytic degradation. The technique
was found to be amenable to cell encapslation, allowing the creation of viable
cellularized high density constructs. The translational aspects of these high density
collagen materials was examined through the ultrastructure and bulk property changes
that may be present through lyophilization and rehydration, as well as comparison against
a gold standard market crosslinked microfibrillar collagen sponge.
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CHAPTER 1. INTRODUCTION

1.1

Introduction

In vivo, cells reside within a tissue specific extracellular matrix (ECM), made up of
a mixture of proteins, primarily Type I collagen. In vivo, collagen exhibits ordering over
several length scales, including molecular (10-9 m), fibrillar (10-6 m), suprafibrillar (10-3
m), and tissue/organ (10-1 m). The chemical and physical properties of this matrix guide
cellular proliferation, migration, and differentiation1. Because of this, tissue engineering
as a field seeks to recapitulate the design features of the natural ECM. Because Type I
collagen makes up around 90% of the ECM, and is highly conserved across tissues and
species, it is a logical choice for a tissue engineering material2, 3 However, to date, there
has been a lack of a tunable collagen material with physiologically relevant properties
and signaling capabilities, limiting collagen’s use in both research and clinical settings.
Soluble monomeric collagens, atelocollagen and telocollagen, are commonly used
in the research setting, and are characterized by the absence of the natural intermolecular
crosslinks found in in vivo collagen4. This protein structure results in the collagen
molecules, upon polymerization, self-organizing into long, randomly oriented fibrils5.
This microstructure is characterized by its low mechanical integrity and rapid proteolytic
degradation6. Monomeric collagen formulations have historically been limited by
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solubility to low collagen fibril densities (<10 mg/mL), further limiting their mechanical
integrity, tunability, and physiological relevance7.
Because of the inherent mechanical weakness present in monomeric collagen
formulations, several techniques have been developed to increase the collagen density
and/or mechanical integrity, and are discussed in detail in Chapter 2. Crosslinking of
collagen attempts to increase the mechanical integrity and resistance to proteolytic
degradation through physical means, such as dehydrothermal treatment, or chemical
means, such as nonspecific glutaraldehyde crosslinking. These techniques increase the
mechanical integrity of the collagen material, but have the drawbacks of destruction of
the microstructure and blocking of the inherent biological signaling capabilities of the
collagen. Increasing the collagen density is typically accomplished through centrifugation
or microinjection with continuous evaporation8, 9. These methods are relatively time
consuming, and, although they allow for cellular migration across them, they typically
are not amenable to cell encapsulation or infiltration10. More recently, removal of the
fluid phase of polymerized telocollagen has been shown to greatly increase the
mechanical integrity and fibril density of the matrix, but the process requires the removal
of nearly the entire fluid phase of the matrix, and resulting materials are very thin (<100
um thick) and brittle11, 12.
In order to overcome the issues with monomeric collagens, decellularized tissues
or fibrillary collagen sponges may be used, and are discussed in Chapter 3.
Decellularized tissues contain the assortment of proteins found in the natural extracellular
matrix outside of collagen, but are subject to the inherent variability of their source
tissues3, 13. Fibrillar collagen sponges are created through lyophilization of slurries of
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insoluble collagen particulate, and are characterized by their amorphous microstructure of
densely packed fibrils separated by large pores hundreds of microns across14. These
sponges are often exogenously crosslinked to create the collagen hemostats and drug
carriers current on the market for clinical use15.
To date there remains an inability to create high-density fibril materials that
recreate hierarchical assembly of collagen found in mature tissues and tunable cellinstructive capacity. This research works to overcome this technology gap using a
hierarchical design strategy focused on molecular level building blocks specified based
on intermolecular crosslink composition and polymerization capacity. To this end, the
Voytik-Harbin lab has developed a method to extract and purify a new collagen building
block, termed collagen oligomer, which represents a new soluble subdomain that falls
between molecular and fibrillar size scales5, 16. Oligomers represent aggregates of
tropocollagen molecules (e.g., trimer) that retain their natural intermolecular crosslink17.
When polymerized, collagen oligomers exhibit suprafibrillar assembly forming
interconnected fibril network and demonstrating mechanical integrity far exceeding that
of conventional monomer collagen formulations6. Previous work has documented that
modulation of polymerization parameters including total collagen concentration and
oligomer to monomer ratio can be used as an effective means to control fibril level
properties, including microstructure, mechanical properties (e.g. stiffness), and
proteolytic degradation, which are all known to guide cell fate18-20. However, oligomer
collagen solutions are still limited to 10 mg/mL by the same solubility constraints that
affect monomer collagen solutions, limiting their potential to create high fibril-density
collagen matrices. To overcome this limitation, a confined compression approach was
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used in this work to forcibly remove a portion of the interstitial fluid low-density
oligomer matrices, effectively creating high collagen-fibril density materials with tunable
material properties.
The specific aims of this research were as follows:
1. Develop and validate the utility of confined compression as a scalable
method for creating tunable high-density collagen-fibril materials and
engineered tissue constructs;
2. Define how lyophilization and rehydration effects the multi-scale structure,
mechanical properties, and proteolytic degradation of high-density
collagen-fibril materials; and
3. Compare ultrastructure, mechanical properties, and proteolytic
degradation of high-density collagen-fibril materials to the commercial
collagen sponge Helistat
Chapter 2 of this thesis addresses Specific Aim 1, while efforts related to Specific
Aim 2 and 3 are descried in Chapter 3. Finally, overall conclusions of the work as well as
opportunities for future studies are addressed in Chapter 4.
Results from this work are important because they support the rational, translational,
and scalable design of a broad range of collagen-based materials and cell-encapsulated
tissue constructs with tissue-like fibril densities, suprafibrillar organizations, and
functional properties for tissue engineering and regenerative medicine applications.
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CHAPTER 2. ACELLULAR AND CELLULAR HIGH-DENSITY, COLLAGENFIBRIL CONSTRUCTS WITH SUPRAFIBRILLAR ORGANIZATION

2.1

Background

In vivo, connective tissue cells reside within a tissue-specific extracellular matrix
(ECM) which primarily represents a highly organized network of densely packed fibrous
proteins, primarily type I collagen fibrils. It is well established that the suprafibrillar
organization and architecture of the collagen contributes to the diversity of structural and
functional properties displayed by the various tissues of the body1. However, more
recently, the microstructure, mechanical properties (e.g., stiffness), and proteolytic
degradation properties of this fibril network have been recognized as powerful
morphogens along with the more widely studied soluble factor and cell-cell signaling21.
Here, type I collagen fibrils instruct fundamental cellular behaviors (e.g., proliferation,
differentiation, migration, and matrix remodeling) associated with tissue development,
maintenance, and repair through their inherent molecular signaling domains, including
those involved in cell adhesion, growth factor binding, and collagen proteolytic
degradation, as well as structural constraints22. As such, it is not surprising that a major
goal of tissue engineering and regenerative medicine is the functional design of
biomaterials and tissues that replicate these essential multi-scale biochemical and
mechanobiology features.
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As the major structural protein of tissues, type I collagen demonstrates not only
hierarchical, multi-scale organization but also the capacity to self-assemble into fibrous
tissues in vivo. As shown in Figure 1, the organizational levels of collagenous tissues
span various size scales including molecular (10-9 m), fibrillar (10-6 m), suprafibrillar (10-3
m), and tissue/organ (10-1 m), with tropocollagen (also known as telocollagen)
representing the fundamental collagen polymer building block. Tropocollagen molecules,
which comprise a central triple helical region flanked by short non-helical telopeptide
domains, participate in a nucleation and growth mechanism to yield microfibrils which in
turn associate laterally and axially to yield fibrils. Proper molecular alignment is driven
by hydrophobic and electrostatic interactions23, 24 with additional adjustments likely
provided by enzyme-mediated molecular crosslinking which further stabilize the
molecular and fibril assemblies25, 26. Although extensive in-vitro study has provided a
detailed mechanistic understanding of the molecular assembly of individual collagen
fibrils (termed fibrillogenesis or fibrillar assembly)24, much less is known regarding
processes associated with suprafibrillar assembly and higher-order organization25. This
knowledge gap has hindered the rational design and development of collagen-fibril
materials and tissue constructs with complex hierarchical architectures and biophysical
and cell-instructive properties found in mature tissues.
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fibrils17. Therefore, even at high densities (10-20 mg/ml), these matrices are associated
with poor shape definition, low mechanical integrity, poor handling, cell-induced
contraction, and rapid proteolytic degradation6, 30-32.
More recently, methods have been described for creating high-density collagenfibril materials from soluble collagen formulations that better approximate the structural
hierarchy and mechanical properties of mature tissues, as seen in Table 1. These methods,
which include reverse dialysis, ultracentrifugation, and evaporation, involve generating
high concentrations of acid-soluble collagen monomers (>20 mg/ml) followed by
neutralization to induce fibrillogenesis. The majority of these approaches were inspired
by current theories and evidence that collagen suprafibrillar organization often mimic
geometries described in liquid crystalline states5. For example, reverse dialysis of low
concentration monomer solutions against poly(ethylene glycol) (PEG)8, 9, 27 has been used
alone or in conjunction with continuous microchamber injection to yield high-density
matrices that are homogenous (250 mg/ml) or display gradients (50-500 mg/ml)33 . A
similar approach involving microinjection and evaporation followed by fibrillogenesis
yielded concentration and ultrastructure gradients extending from 5-1000 mg/ml10.
Unfortunately, these approaches require long production times (weeks to months) and are
not amenable to cell encapsulation. Furthermore, while these high density materials
support cell adhesion and growth along the surface, migration or infiltration into the
material is limited34, 35.
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Table 1 – Densification Strategies
Cell
Process

Neutralization

Final Formulation

Mechanical Properties

Ref
Encapsulation

centrifugation
prior to

10-20 mg/mL

up to 70kPa elastic

PBS
polymerization;

Puetzer, 2013. Elsdale,
yes

constructs

modulus

1972.

90 min
continuous
injection/

thin matrices up to
ammonia vapor

evaporation;

Mosser, 2006. Besseau,
not shown

no

1000 mg/mL

1995.

weeks to months
reverse dialysis
with PEG prior
Titration of
to

Saeidi, 2012. Knight
375 mg/mL

not shown

No

PEG

1998.

polymerization;
24 hours
post
yes, but cell
polymerization

Neel, 2006. Bitar, 2007.
dense thin sheets

unconfined

DMEM and

death under
up to 4 Mpa elastic

(~98% weight
compression/

NaOH

Cheema, 2013. Mudera,
extreme

modulus
loss)

2007. Brown, 2005.
compressive

absorbtion; 5

Hadjipanayi, 2009.
conditions

min

An alternative 2-step method for achieving high-density collagen-fibril materials
that is more amenable to cell encapsulation involves polymerization of low concentration
monomer solutions followed by unconfined plastic compression and/or capillary fluid
flow into blotting paper layers to reduce the interstitial fluid content 11. Here, low-loads
(50-60 g or 1.1 kPa) are applied to the top of a collagen matrix (~ 2-5 mg/ml) to achieve
fluid reduction (~85-99.8% compressive strain) through a supporting nylon mesh11, 36.
The resulting sheets, which are 20 to 100 um in thickness, are fragile, requiring spiraling
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to facilitate handling and further testing. They display tensile strength and modulus
values of 0.6 ± 0.11 MPa and 1.5 ± 0.36 MPa, respectively, and support 85% viability of
encapsulated cells12. Additional compression of spiraled constructs improves
mechanical integrity but reduces cellular viability12, 36.
In the present work, we demonstrate the benefit of combining suprafibrillar
assembly with fibril-matrix densification strategies for creating broadly customizable,
scalable, high-density collagen-fibril constructs in the presence and absence of cells. The
first step involves the use of standardized collagen oligomers to prepare low
concentration matrices (<10 mg/ml) with specified and highly reproducible
microstructure and physical properties (intermolecular crosslink content, fibril density,
interfibril branches, and proteolytic degradability). Oligomers, which represent soluble
aggregates of tropocollagen molecules (e.g., trimers) that retain their natural
intermolecular crosslinks, exhibit not only fibrillar but also suprafibrillar assembly. Next,
confined, rather than unconfined, compression is applied to controllably reduce fluid
content and increase the fibril density. Interestingly, we show that this approach is not
applicable to collagen-fibril matrices prepared from conventional collagen monomer
preparations, telocollagen and atelocollagen. This is largely owing to their limited selfassembly capacity and inability to yield fibril microstructures that can sustain or support
the associated compressive and fluid shear forces. Results from this work are important
because they support the rational and scalable design of a broad range of collagen-based
materials and cell-encapsulated tissue constructs with tissue-like fibril densities,
suprafibrillar organizations, and functional properties for tissue engineering and
regenerative medicine applications.
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2.2

2.2.1

Materials and Methods

High-Density Collagen-Fibril Construct Preparation

Type I collagen oligomers were acid solubilized from dermis of market weight pigs
and lyophilized for storage as described previously18. Prior to use, the lyophilized
collagen was dissolved in 0.01 N hydrochloric acid (HCl) and rendered aseptic by
chloroform exposure at 4°C. Collagen concentration was determined using a Sirius Red
(Direct Red 80) assay37. The oligomer formulation was standardized based upon purity
as well as polymerization capacity according to ASTM standard F3089-1438. Here,
polymerization capacity is defined by matrix shear storage modulus (G’) as a function of
collagen concentration of the polymerization reaction. Commercial acid-soluble rat tail
collagen (telocollagen) and pepsin-solubilized bovine dermis collagen (atelocollagen)
were obtained from Corning (Corning, NY) and Advanced BioMatrix (Carlsbad, CA),
respectively. All collagen solutions were diluted with 0.01 N HCl to achieve desired
concentrations and neutralized with 10X phosphate buffered saline (PBS) and 0.1N
sodium hydroxide (NaOH) to achieve pH 7.417. Neutralized solutions were kept on ice
prior to inducing polymerization by warming to 37°C.
All acellular oligomer collagen-fibril constructs were prepared with an initial
starting collagen concentration of 3.5 mg/ml in 2 cm X 4 cm block molds. After
polymerization and incubation at 37°C for 1 hour (tensile testing only) or 18 hours (used
for all tests), each construct was compressed within the block mold to a final thickness of
2 mm (1.6 mL volume) with a porous polyethylene platen (50 µm pore size; Scientific
Commodities, Inc., Lake Havasu City, AZ) at a rate of 6 mm/min. Final construct

12
collagen concentration was controlled by varying the initial polymerized collagen volume.
More specifically, starting volumes of 1.6 mL, 5.6 mL, and 11.2 mL of 3.5 mg/mL
collagen (initial concentration) were differentially compressed to yield 3.5 mg/ml (no
compression), 12.25 mg/ml (71% strain), and 24.5 mg/mL (86% strain) constructs,
respectively. Assuming all collagen polymerized, these constructs represented collagen
wet weights (w/w) of 0.6%, 2.1% and 4.2%, respectively, as measured from the masses
of hydrated and lyophilized constructs (data not shown). Commercial telocollagen and
atelocollagen were polymerized to a collagen concentration of 3.5 mg/mL and allowed to
polymerize at 37C for 18 hours before being subjected to compression identical to that
detailed above to 86% strain.
2.2.2

Collagen Fibril Micro- and Ultra-Structure Analysis

The fibril microstructure and ultrastructure of the collagen constructs was
visualized using confocal reflection microscopy39 and cryo-SEM40, respectively.
Confocal reflection microscopy was performed using an Olympus Fluoview FV-1000
confocal system adapted to an Olympus IX81 invested microscope with a 60X
UPlanSApo water immersion objective (Olympus, Tokyo, Japan). Cryo-SEM images of
samples were obtained using an FEI NOVA nanoSEM 200 (FEI, Hillsboro, OR).
Samples were quick frozen by submersion into liquid nitrogen cooled to its triple point,
transferred to a CT1000 coldstage attachment (Oxford Instruments North America, Inc.,
Concord, MA), and sublimated under vacuum before sputter coating and imaging.
Collagen constructs used for AFM analysis of D-periodic banding were
extensively rinsed with water and then air dried. Samples were imaged in air using a
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Bruker BioScope Catalyst AFM (Bruker Corporation, Santa Barbara, CA ) as described
previously41. In brief, images were acquired in a peak force tapping mode using
ScanAsyst Fluid+ probes (silicon tip, silicon nitride cantilever, nominal tip radius 2 nm
and nominal stiffness of 0.7 N/m). From each sample (n=4 per group), 15-20 fibrils at
each of 2 locations were imaged and analyzed (~150 total fibrils per group). Twodimensional fast fourier transforms were performed and the primary peak from the 2D
power spectrum was analyzed to determine the value of the D-periodic spacing for
individual fibrils.
2.2.3

Mechanical Testing

Tensile testing was performed on dog-bone shaped collagen constructs with a
gauge length, width, and thickness of 26 mm, 4 mm, and 2 mm, respectively. All samples
were tested in uniaxial tension to failure at a strain rate of 10 mm/second using a servo
electric materials testing system (Testresources, Shakopee, MN). Stress measurements
were obtained using a 10 lb load cell (LPM 512, Cooper Instruments, Warrenton, VA) at
a sampling rate of 100 Hz. Engineering tensile modulus (ET) was calculated from the
linear region of the stress strain curve. Ultimate stress (ᆓU) represented peak stress
experienced by the sample, and failure strain (ܭf) was the strain at which constructs
experienced total failure. (n=7).
2.2.4

Proteolytic Degradability

Proteolytic degradation was measured by measuring compressive modulus and
hydroxyproline content of constructs before and after 2-hour exposure to bacterial
collagenase type IV (31.2 U/mL; Worthington, Lakewood, NJ). Collagen constructs
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prepared at 3.5, 12.25, and 24.5 mg/mL were punched to form cylinders with diameter
and thickness of 1 cm and 2 mm, respectively. Constructs were tested in unconfined
compression at 17%/second to 75% strain using a servo electric materials testing system
(Testresources, Shakopee, MN) adapted with a 10 lb load cell (LPM 512, Cooper
Instruments, Warrenton, VA). Compressive modulus was calculated as the slope of the
linear region of the stress-strain curve. Compression tests were performed on seven
independent constructs per group (n=7). Control and collagenase-treated constructs were
then subjected to a spectrophotometric-based hydroxyproline assay (Sigma Aldrich) to
determine collagen content.
2.2.5

Cellularized High-Density Tissue Construct Preparation

Low passage human adipose-derived stem cells (hASC) were obtained from ZenBio (Research Triangle Park, NC). Cells were cultured in 50/50 mixture of DMEM/F12
medium (Life Technologies, Carlsbad, CA) with 10% FBS, 100 U/mL Penicillin, and 100
U/mL Streptomyosin (Invitrogen, Grand Island, NY). hASC were grown and maintained
in a humidified environment of 5% carbon dioxide in air at 37°C. Cells were kept below
80% confluence and used in experiments at passage 6 to 9.
To create cellularized, high-density, collagen-fibril constructs, hASC were added
to neutralized oligomer solutions (3.5 mg/mL) and polymerized for 15 minutes at 37°C
(Figure 7). Tissue constructs representing different volumes, specifically 50 µL, 175 µL,
or 350 µL, were created in glass-bottom 96-well plate (Corning, Corning, NY).
Constructs were densified to 1.5 mm final thickness (50 µL volume) at 6 mm/min using a
porous polyethylene platen (Scientific Commodities, Inc.). Final hASC density within
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constructs was 5 x 105 cells/mL. Immediately following densification, 200 µL of medium
was added to each well and tissue constructs were maintained in a humidified
environment at 37oC and 5% CO2 in air with medium changes every 24 hours.
Cell viability was evaluated at 48 hours by staining with Celltracker (5chloromethylfluorescein diacetate; Molecular Probes, Eugene, OR) and propidium iodide
(Sigma-Aldrich). Confocal images stacks (50-µm thick) were collected and used for
live/dead analyses (n=6). Cell morphology and cell-matrix interactions were assessed by
staining constructs with phalloidin (Molecular Probes, Eugene, OR) and Draq5 (Biostatus
Limited, Leicestershire, United Kingdom) for visualization of F-actin and the nucleus,
respectively.
2.2.6

Statistical Analysis

Statistical analysis was performed in Minitab statistical software. One-way
ANOVA was applied across collagen concentrations (3.5, 12.25, and 14.5 mg/mL) with a
Tukey post-hoc test to determine differences in mean values. In cases where population
variances were not equal (ultimate stress, elastic modulus, compressive modulus), a
Kruskal-Wallis test was performed in place of ANOVA with post-hoc 2-sample T-tests
assuming non-equal population variances. Mean D-periodic spacing values were
compared using an ANOVA and a post-hoc Holm-Sidak test. To examine differences in
the distribution of fibril D-periodic spacing values, the Cumulative Distribution Function
(CDF) of each group was computed and statistically compared using a KolmogorovSmirnov (KS) test. A critical global p-value of 0.05 was used.
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2.3

2.3.1

Results and Discussion

Type I Collagen Oligomers Demonstrate in-vitro Fibrillar and Suprafibrillar
Assembly and Support Confined Compression

Recently, we described the isolation and purification of type I collagen oligomers,
which appear to represent a new soluble subdomain that falls between molecular and
fibrillar size scales16, 17. As shown in Figure 1B, oligomers represent tissue-derived
aggregates of tropocollagen molecules (e.g., trimer) that retain their natural
intermolecular crosslink. Unlike conventional collagen monomers, oligomers exhibit
rapid fibril and suprafibrillar self-assembly yielding highly interconnected collagen-fibril
matrices with dramatically improved mechanical integrity, handling, and reduced
proteolytic degradation6. As a result when polymerized at the same final collagen
concentration, oligomer matrices have dramatically improved shape retaining capacity,
mechanical integrity, and resistance to cell-induced contraction compared to their
monomer counterparts5. More specifically, the stiffness range prepared for oligomer
matrices prepared at 0.5-4 mg/ml was 40-1500Pa, while that for telocollagen and
atelocollagen preparations was 2-300Pa and 2-50Pa, respectively6.
Here, high resolution AFM images (Figure 2) were used to confirm that lowdensity oligomer matrices represent highly interconnected fibril networks with Dperiodic spacing resembling that found in vivo. As shown in Figure 2A-C, component
fibrils within oligomer and telocollagen but not atelocollagen matrices displayed highly
regular and prominent D-periodic spacing patterns. These results confirm previous
studies demonstrating the essential role of the non-helical telopeptide regions in guiding
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can be used to drastically improve mechanical properties and proteolytic degradability of
collagen-fibril materials in absence of exogenous crosslinking and other processing.
Since stress-strain behavior of reconstituted collagen matrices has been shown to
be dependent upon polymerization time17, oligomer matrices were polymerized for 1 hour
or 18 hours, prior to densification and follow-up tensile testing. Despite the
polymerization time, confined compression resulted in high-density collagen-fibril
constructs with increased ultimate strength and elastic modulus. While polymerization
time did not significantly affect mean mechanical property values, constructs
polymerized for 18 hour showed improved reproducibility as evidenced by reduced
standard deviation. As such an 18-hour polymerization time was adopted as a preferred
mode.
Comparison of collagen-fibril constructs prepared at 3.5, 12.25, and 24.5 mg/ml
showed that both ultimate stress and elastic modulus increased in a nearly linear fashion
with collagen content (Figure 5). Ultimate stress values showed statistically significant
increases from 65.7 kPa to 120.8 kPa to 212.9 kPa for 3.5, 12.25, and 24.5 mg/mL
samples, respectively (p<0.01). Likewise, elastic modulus increased in a statistically
significant fashion from 0.40MPa to 0.88MPa to 1.26 MPa over the range tested (p<0.05;
Figure 5). All samples, regardless of densification, failed near 0.28 mm/mm strain (Table
2). The significant contribution of higher-order suprafibrillar assembly to the mechanical
properties of densified collagen-fibril constructs is evident upon comparison of results
obtained in the present study with oligomer collagen with those obtained with previously
with conventional monomer formulations. More specifically, telocollagen required
densification via unconfined compression to approximately 100 mg/ml, removing nearly
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Densification of collagen-fibril constructs was also found to modulate in-vitro
proteolytic degradation properties as measured using collagenase from Clostridium
histolyticum. While the specificity of mammalian collagenase is more limited compared
to bacterial collagenase, good empirical correlation between the extent of in-vitro
degradation by bacterial collagenase and in-vivo degradation by mammalian collagenase
has been documented47. Qualitative and quantitative assessment of collagenase
degradation (Figure 6) showed that the extent of densification affected not only the
degradation rate but also to some extent the degradation mechanism (surface versus bulk).
Following 2-hour exposure, the 3.5 mg/mL constructed was nearly entirely
degraded, while the 12.25 mg/ml and 24.5 mg/ml constructs showed markedly higher
collagenase resistance. Interestingly, 12.25 mg/mL constructs appeared to develop small
degraded regions throughout the surface area of the construct, consistent with bulk
degradation. In contrast, degradation of the 24.5 mg/mL construct appeared more
concentrated to the edges indicative of more limited diffusivity and surface degradation.
Proteolytic degradation of the constructs also was defined and compared quantitatively
based on the change in compressive modulus before and after 2-hr collagenase treatment
(Figure 6B). Here, as shown in Figure 6C, collagenase-treated 3.5 mg/ml constructs
showed a dramatic reduction in compressive modulus to 6.7% of untreated controls. In
contrast, 12.25 mg/ml and 24.5 mg/ml samples showed significantly reduced levels of
collagenase degradation with compressive modulus values of 47% and 71% of untreated
controls. The collagenase induced changes in mechanical performance correlated well
with collagen content as measured using conventional hydroxyproline assay (Figure 6D).
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tissue engineering applications48, 49. Cell viability, morphology, and F-actin (phalloidin)
distribution then were assessed after 48 hours of culture. Control 3.5 mg/mL constructs
showed 94.29 ± 2.42% cell viability, while viability within densified 12.25 mg/ml and
24.5 mg/mL constructs was 89.57 ± 2.43 and 88.96 ±2.48%, respectively (Table 3).
Although cell viability remained high in all cases, values for densified constructs were
statistically lower than the control (p<0.05), but not statistically different from each other
(p=0.65). Collectively, these results document that the compressive loads, fluid shear
forces, and high fibril densities do not compromise cell health.
Visualizing F-actin organization (phalloidin) within hASCs encapsulated within
various high-density collagen-fibril constructs provided important insights regarding the
cell-collagen interactions and associated mechanobiology signaling. The actin
cytoskeleton is well recognized for its role in cell morphology as well as establishing
physical linkage between the cell interior and collagen fibrils of the extracellular matrix
through focal adhesions50. Here, encapsulated hASCs were able to sense and respond to
the different mechanobiology cues provided by the 3 different collagen constructs as
demonstrated by their markedly different morphologies and F-actin distributions (Figure
7C-E). In the control 3.5 mg/mL constructs, cells were spindle-shaped and elongated with
prominent actin stress fibers along their long axis. Cells encapsulated within 12.25 mg/ml
and 24.5 mg/ml constructs responded to the progressive increase in fibril density and
associated matrix stiffness by taking on more stellate and polygonal morphologies,
respectively. Furthermore, actin stress fibers became less prominent with the adoption of
a more uniformly-distributed, punctate F-actin staining pattern. These morphology and
cytoskeletal changes are consistent with previous reports, and reflect modulation of the
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2.4

Conclusion

The development of functional tissue constructs for research and medical
applications requires an in-depth understanding of how cells interact and respond to the
surrounding extracellular matrix. Since collagen exists in vivo as fibers and is the major
component of connective tissue, oligomeric collagen-fibril matrices provide a highly
physiologically relevant system. A key finding of this work is the benefit of oligomers
and their associated suprafibrillar assembly capacity for creating acellular or cellular
collagen-fibril constructs with tissue-like appearance, handling, and performance.
Densification of oligomer collagen matrices irreversibly removed a portion (71-86%) of
the fluid from the material, reproducibly creating novel materials with the collagen
concentration and strength of soft connective tissues. The material is capable of being
made without the use of any exogenous crosslinking chemicals or matrix destroying
processes, retaining the collagen’s in vivo branched fibril microstructure. The
densification process was shown to be amenable to creating high density cellularized
tissue constructs. This material, with its hierarchical tuning capability of material
properties, shows large promise for tissue engineering applications and basic science
studies, such as three dimensional cell culture.
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CHAPTER 3. TRANSLATIONAL DESIGN ASPECTS OF HIGH-DENSITY
COLLAGEN-FIBRIL CONSTRUCTS

3.1

Introduction

Collagen is the major structural element of connective tissues and the prominent
component of the extracellular matrix. Its suprafibrillar assembly and hierarchical
organization varies from tissue to tissue bringing diversity in form and function1. In
addition to conferring structure and mechanical properties to the body’s tissues and
organs, this natural polymer has been more recently recognized for its critical role in
cellular signaling associated with tissue development, maintenance, and repair53. Both
in-vitro and in-vivo studies have shown that the collagen fibril microstructure and
stiffness of the cell microenvironment provide important guidance cues that regulate not
only fundamental behavior of differentiated cells but also differentiation and
morphogenesis of multipotent stem cells54. Instrumental to this mechanobiology
signaling are molecular signaling domain for cell adhesion, proteolytic degradation, and
growth factor binding inherent to the tropocollagen molecule, which represents the
fundamental collagen building block55.
The clinical applications of collagen have been limited by the non-in vivo like
state of collagen products. To date, collagen-based material and tissue design for both
research and medical applications has relied on a limited number of collagen

28
formulations known to vary in purity and biomechanical and biochemical signaling
capabilities. A variety of collagen materials have seen extensive clinical use as
biodegradable hemostatic agents, bulking agents for plastic surgery, wound coverings and,
more recently, as biodegradable drug delivery vehicles3. Formulations used to date
include purified collagen gels, decellularized matrices, and fibrillary collagen sponges.
These materials create a more biological interface between the body and the wound,
aiding the healing process. Due to the biodegradability of the collagen, which is lessened
by crosslinking through physical or chemical means in some forms, the materials can be
left in after surgery and slowly degraded and removed from the body with minimal
adverse reactions15. However, the clinical uses of collagen to date do not readily take
advantage of the biomechanical and biochemical signaling capabilities of the collagen.
Collagen has seen extensive use, particularly in research applications, in the form
of purified collagen solutions which can form gels. This form of collagen has the clinical
advantage of being injectable, and forming a gel within the body. However, the dissolved
collagen solutions are limited in concentration by solubility, and are traditionally
monomeric collagen formulations5. Monomeric collagen formulations lack the natural
intermolecular crosslinks found in in vivo collagen, severely limiting the polymerization
capacity of the solution as well as the mechanical integrity of the polymerized gel18.
Films of collagen have been used in combination with other materials or cells as a
treatment for burns, due to their impermeability to bacteria and low antigenicity14,
56

.Soluble, polymerizable monomeric collagen has been used in combination with cells in

an FDA approved skin substitute under the trade name of Apligraf. Apligraf consists of a
collagen matrix which has been contracted by human fibroblasts. This method of action,
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cellular contraction, to create a higher collagen fibril density matrix functions due to the
inherent weakness found in these monomeric collagens, which allows the force of the
cells to tightly contract the matrix. In addition, the inclusion allogenic cells can illicit an
immunogenic response from the recipient.
In order to overcome the low mechanical integrity of collagen formulations,
decellularized tissues have been used. These materials consist of the extracellular
matrices of natural tissues, such as small intestine or urinary bladder, with the cells
removed, retaining the mixture of proteins naturally found in the donor site13. Other
tissue sources used include heart valves, skin, and skeletal muscle3. However, these
materials are subject to more inherent variability, as the individual differences between
donor sites are not removed. As such, the microstructure, protein makeup, and
mechanical properties are all subject to variances in the humans and animals they are
obtained from57. These products can also be exogenously crosslinked to gain higher
mechanical integrity, but at the cost of the natural biochemical signaling capabilities of
that tissue.
Insoluble collagens (also referred to as fibrillar collagens) that don’t polymerize
are routinely fashioned into high-density, porous collagen sponges through lyophilization
of collagen slurries. To create these products, tissue sources high in collagen content,
such as tendon, are milled into particulate, washed to remove excess proteins such elastin,
crosslinked, frozen, and lyophilized. Overall, these materials have amorphous (nonfibrillar) microstructures and are often further subjected to exogenous chemical or
physical crosslinking to improve mechanical properties and decrease proteolytic
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degradability. The collagen causes platelets to clot upon contact, allowing control over
blood loss during surgery58.
The collagen sponges have also seen recent clinical use as drug delivery vehicles
for a number of drugs, including gentamicin and rh-BMP215. In these forms, the
lyophilized collagen sponge is soaked in solution containing the drug prior to
implantation in the body. The sponge is then degraded by the body, allowing some
extended release of drug into the body, and the collagen sponge is degraded and removed
from the body over time.
In short, the currently available collagen formulations lack the in vivo
microstructure, resistance to degradation, and mechanical integrity of natural collagen,
and in order to regain some of the lost mechanical integrity, as in exogenous crosslinking,
the natural microstructure is further damaged. This process leaves the collagen materials
with properties that are far exceeded by the natural collagen, and are unfit to guide
cellular fate and behavior in a clinically relevant fashion. This lack of a physiologically
relevant form of processed collagen must be overcome to take clinical advantage of the
collagen’s biochemical and biophysical signaling capabilities for tissue engineering and
regenerative medicine applications.
Recently, we described the isolation and purification of type I collagen oligomers,
which appear to represent a new soluble subdomain that falls between molecular and
fibrillar size scales6. Oligomers represent aggregates of tropocollagen molecules (e.g.,
trimer) that retain their natural intermolecular crosslink. More specifically,
characterization studies performed to date suggest that oligomers purified from porcine
dermis represent a prong-shaped molecule in which three molecules are covalently
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connected at Į1-Hyl 87, Į2-His 92, and Į1-Lysald 16c amino acid residues by the
histidinohydroxylysinonorleucine crosslink18, 59. Unlike conventional collagen monomers,
oligomers exhibit rapid fibril and suprafibrillar self-assembly yielding highly
interconnected collagen-fibril matrices with dramatically improved mechanical integrity,
handling, and reduced proteolytic degradation. More recently, low-density matrices were
found to exhibit plastic deformation when subjected to confined compression, creating
high density (>10 mg/mL) collagen-fibril materials that appear and handle like soft
connective tissues and support cell encapsulation. More specifically, the plastic
deformation created collagen fibril materials with tunable elastic moduli ranging from
400 kPa to 1.3 MPa, with 90% cell viability exhibiting different encapsulated hASC
morphology at 48 hours post-densification. The process was also found to be capable of
creating gradients in collagen fibril density and alignment.
Here we extend this work by evaluation lyophilization as a means to promote
stability, preserve biological function, and facilitate long-term storage of high-density
collagen-fibril materials. Lyophilization represents the current industry standard for
prolonging the shelf life of collagen and other biologically based materials60. Studies
involved high density collagen-fibril materials, representing 24.5 mg/mL oligomeric
collagen. Multi-scale structural properties, mechanical behavior, and proteolytic
degradation are compared before and after lyophilization and rehydration. In addition,
this high density collagen-fibril material is compared to Helistat, a commercial collagen
sponge used for hemostasis and drug delivery15, 61. Results document how the
suprafibrillar assembly of collagen oligomers dramatically improves the mechanical

32
integrity of biosynthetic collagen biomaterials while maintaining a highly porous
collagen-fibril microenvironment with tunable mechanobiology signaling.

3.2

3.2.1

Materials and Methods

Preparation of High-Density Oligomer Collagen-Fibril Materials

Type I collagen oligomers were acid solubilized from dermis of market weight
pigs and lyophilized for storage as described previously6. Prior to use, lyophilized
collagen was dissolved in 0.01 N hydrochloric acid (HCl) and rendered aseptic by
chloroform exposure at 4°C. Collagen concentration was determined using a Sirius Red
(Direct Red 80) assay 30. The oligomer formulation was standardized based upon purity
as well as polymerization capacity according to ASTM standard F3089-14 38. Here,
polymerization capacity is defined by matrix shear storage modulus (G’) as a function of
collagen concentration of the polymerization reaction. Oligomer solutions were diluted
with 0.01 N HCl to achieve desired concentrations and neutralized with 10X phosphate
buffered saline (PBS) and 0.1N sodium hydroxide (NaOH) to achieve pH 7.4 18.
Neutralized solutions were kept on ice prior to inducing polymerization by warming to
37oC.
Oligomer collagen-fibril matrices were prepared with an initial starting collagen
concentration of 3.5 mg/ml in 2 cm X 4 cm block molds. After polymerization and
incubation at 37°C for 18 hours, each matrix was compressed within the block mold to a
final thickness of 2 mm (1.6 mL volume) with a porous polyethylene platen (50 µm pore
size; Scientific Commodities, Inc., Lake Havasu City, AZ) at a rate of 6 mm/min. Final
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collagen concentration was controlled by varying the initial polymerized collagen volume.
More specifically, a starting volume of 11.2 mL of 3.5 mg/mL collagen (initial
concentration) were compressed to yield 24.5 mg/mL (86% strain) constructs.
Commercial Collagen sponges (Helistat) were purchased from Miltex (York, PA).
3.2.2

Collagen Biomaterial Micro- and Ultrastructure Analysis

The fibril micro- and ultra-structure of the commercial Helistat collagen sponge
and oligomer collagen-fibril materials were visualized using SEM as well as cryo-SEM.
SEM and Cryo-SEM images of samples were obtained using an FEI NOVA nanoSEM
200 (FEI, Hillsboro, OR). Lyophilized samples were mounted and sputter coated under
vacuum prior to imaging. Rehydrated samples were quick frozen by submersion into
liquid nitrogen cooled to its triple point, transferred to a CT1000 coldstage attachment
(Oxford Instruments North America, Inc., Concord, MA), and sublimated under vacuum
before sputter coating and imaging.
3.2.3

Mechanical Testing

Tensile testing was performed on dog-bone shaped rehydrated collagen constructs
with a gauge length, width, and thickness of 26 mm, 4 mm, and 2 mm, respectively. All
samples were tested in uniaxial tension to failure at a strain rate of 10 mm/second using a
servo electric materials testing system (Testresources, Shakopee, MN). Stress
measurements were obtained using a 10 lb load cell (LPM 512, Cooper Instruments,
Warrenton, VA) at a sampling rate of 100 Hz. Engineering tensile modulus (ET) was
calculated from the linear region of the stress strain curve. Ultimate stress (VU)
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represented peak stress experienced by the sample, and failure strain (Hf) was the strain at
which constructs experienced total failure. (n=7).
3.2.4

Suture Retention

Helistat collagen sponges and lyophilized high-density oligomer collagen-fibril
matrices were hydrated and their suture retention strength quantified according to ASTM
standard protocol STP89862. Prolene suture (5-0) was looped through the material at a
“bite distance” (distance between the edge of the material and the suture) of 1.5 mm [7].
The suture then was looped through a hook connected to a servo electric materials testing
system (Testresources, Shakopee, MN) and tied using several square knots to prevent
slipping. The suture was then pulled by the tensile tester at a crosshead speed of 25.4
mm/min until failure, and the peak force was recorded in grams. Force measurements
were obtained using a 10 lb load cell (LPM 512, Cooper Instruments, Warrenton, VA) at
a sampling rate of 100 Hz. (n=7).
3.2.5

Proteolytic Degradability

Proteolytic degradation was assessed by measuring compressive modulus of
constructs before and after 2-hour exposure to bacterial collagenase type IV (31.2 U/mL;
Worthington, Lakewood, NJ). Helistat collagen sponge and oligomer collagen-fibril
material (24.5 mg/ml) were punched to form cylinders with diameter and thickness of 1
cm and 2 mm, respectively. Constructs were tested in unconfined compression at
17%/second to 75% strain using a servo electric materials testing system (Testresources,
Shakopee, MN) adapted with a 10 lb load cell (LPM 512, Cooper Instruments, Warrenton,
VA). Compressive modulus was calculated as the slope of the linear region of the stress-
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strain curve. Compression tests were performed on seven independent constructs per
group (n=7).
3.2.6

Statistical Analysis

For each measure, two-sided t-tests were performed between the high-density
oligomer collagen-fibril matrices and the commercial collagen sponges with a critical pvalue of 0.05.
3.3

3.3.1

Results and Discussion

Rehydrated High-Density Oligomer Collagen-Fibril Matrices

3.3.1.1 Ethanol Rehydration Preserves Marcrostructure and Ultrastructure
Lyophilization is a useful tool for prolonging the shelf life of collagen or other
biologically based materials. Lyophiliztion of decellularized urinary bladder extracellular
matrix was found to have minimal effects on the mechanical properties over a year after
the lyophilization occurred, whether stored in a room temperature or refrigerated
environment63. When rehydrated using water or 1X phosphate buffered saline, the highdensity oligomer collagen-fibril matrices experienced macrostructure collapse, decreasing
in thickness from 2 mm to approximately 0.4 mm. When first subjected to the short
incubation in ethanol, the high-density oligomer collagen-fibril matrices retained their
macrostucture thickness of 2 mm. This pattern was examined using graded mixtures of
HWKDQROLQZDWHUDQGVKRZHGWKDWDWHWKDQROE\YROXPHDVXUIDFHWHQVLRQRI
mN/m64, the solution caused collapse of the high-density oligomer collagen-fibril matrix,
ZKLOHDWHWKDQROE\YROXPHDVXUIDFHWHQVLRQRIP1P64 the structure did not
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collapse (Figure 8). During rehydration with water only, the rehydration and collapse
took place over a long period of time, on the order of an hour. Ethanol rehydration, in
contrast, was complete in under one minute, and the replacement of ethanol with water
when placed in the water bath happened over a short timescale as well, complete in under
5 minutes.
The differences in rehydration are likely due to the effect of the surface tension on
the fibril microstructure of the oligomeric collagen, as limiting osmotic forces and
surface tension are critical for optimal rehydration. Ethanol in particular has previously
been shown to be a useful tool in the rehydration of chitosan scaffolds65. Under
rehydration with solutions with relatively high surface tension, the fibrils are bent and
buckled by the incoming force of the fluid, collapsing the structure. When rehydrated
using solutions with low surface tension, such as ethanol, the force on each fibril is low
enough for the microstructure to withstand the force of the incoming fluid.
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oligomer collagen-fibril matrix was very similar to that seen in the lyophilized oligomer
sponge, being made up of an interconnected, branched collagen fibril network.
3.3.1.2 Mechanical Properties of Rehydrated High-Density Oligomer Collagen-Fibril
Matrices
The high-density oligomer collagen-fibril matrices showed an average ultimate
tensile stress of 196.9 ± 66.0 kPa, failure strain of 0.33 ± 0.03 mm/mm, and elastic
modulus of 1.29 ± 0.52 MPa. The ultimate stress, failure strain, and elastic modulus of
the rehydrated high-density oligomer collagen-fibril matrix were all found to be
statistically similar to those of the oligomeric collagen of identical preparation that had
not undergone a lyophilization procedure. The suture retention strength of the highdensity oligomer collagen-fibril matrix was 0.54 ± 0.16 N. Data summarized in Figure 9.
The oligomeric collagen was found to have a statistically similar suture retention strength
to the rehydrated high-density oligomer collagen-fibril matrix, with a suture retention
strength of 0.65 ± 0.21 N. Overall, no differences were found between the mechanical
properties of the hydrated and rehydrated high-density oligomer collagen-fibril matrices.
The properties of the polymerized high-density oligomer collagen-fibril matrix are orders
of magnitude higher than the 1-30 kPa elastic modulus seen in polymerized monomeric
collagen formulations6. In addition, the elastic modulus values are similar to those seen
for SIS (0.8-1.6 MPa), a commonly used decellularized tissue product66.
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ultrastructure was shown to be made up of regions of dense compacted fibrils separated
by large pores up to several hundred microns across.
3.3.2.2 Mechanical Properties
The Helistat commercial collagen sponges showed an average ultimate tensile
stress of 47.8 ± 7.4 kPa, failure strain of 0.32 ± 0.08 mm/mm, and elastic modulus of 0.27
± 0.03 MPa. Data shown in Figure 12. The high-density oligomer collagen-fibril matrix
was found to have statistically significantly higher values for ultimate stress and elastic
modulus, and a statistically similar value for failure strain. The high-density oligomer
collagen-fibril matrix having an order of magnitude higher elastic modulus than the
Helistat is quite noticeable considering the high-density oligomer collagen-fibril matrix
contains no exogenous crosslinking, while the Helistat is formaldehyde crosslinked. This
increased elastic modulus also brings the material properties of the high-density oligomer
collagen-fibril matrix into the realm of soft tissues found in the body, implying its
usefulness in reconstructive surgery as a tissue replacement. The suture retention strength
of the Helistat commercial collagen sponge was 0.34 ± 0.08 N. The high-density
oligomer collagen-fibril matrix was found to have a statistically significantly higher
suture retention strength, although both fall short of the generally accepted 2N
requirement for surgical use67. The elastic modulus of the Helistat is similar to the 50-200
kPa elastic modulus reported for collagen-GAG sponges crosslinked with
dehydrothermal treatment, UV irradiation, and/or glutaraldehyde68. Overall, the highdensity oligomer collagen-fibril matrix was shown to have nearly double the suture
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those levels found in soft tissues. This is important as the mechanical properties of the
extracellular matrix have been found to have an overwhelming effect on the cells that
interact with it, so much so that the mechanical cues can override the signals given by
soluble factors in vitro. Even more notable is that the high-density oligomer collagenfibril matrix was capable of achieving such high mechanical properties without the need
for exogenous aldehyde crosslinking, which is known to have deleterious effects on the
biological signaling capabilities of collagen, as well as potentially harmful cellular
responses45. The creation of a tissue-like collagen sponge material which can be
lyophilized and stored for long periods before use as a tissue replacement could have
great utility as a soft tissue replacement for mastectomies, or as a tissue replacement for
deep burn wounds or ulcers. These materials may allow for full integration into the
patient and allow for exemplary healing. In the cases of hard tissue replacement and void
filling, such as bone, the increased material properties will likely lead to more adequate
bone formation due to the strength and density of the matrix giving cues to the natural
osteoclasts and osteoblasts responsible for bone growth and repair. These claims require
further study into the in vivo behavior of these high-density oligomer collagen-fibril
matrices.
The use of ethanol as a rehydrating agent allowed the collagen materials to retain
their pre-lyophilization ultrastructure and mechanical properties. Ethanol is often used in
the laboratory setting as a sterilization solution, and has been shown to have limited
effects on the properties of collagen matrices68.
Overall, the materials created for this study provide the controllable
microstructure and repeatability of polymerizable collagen, the natural biophysical
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signaling properties and mechanical properties of decellularized tissue, and the long term
storage and ease of use of fibrillary collagen sponges, without the need for any
exogenous crosslinking.
It should be noted that the high-density oligomer collagen-fibril matrix has not
undergone sterilization, as the Helistat has, and this has been known to have an effect on
the mechanical properties of collagen based products. However, the effects of
sterilization, and in particular ETO sterilization which is commonly used for collagen
based products, have been non-substantial changes in integrity, cellular proliferation, or
proteolytic degradation, and an increase in tensile strength.
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CHAPTER 4. CONCLUSION

4.1

Conclusions

The oligomeric collagen formulations have a distinct advantage over other
monomeric collagen formulations because of their innate ability to self-assemble into
branched fibril networks similar to those found in collagen in vivo. This microstructure
shows drastic mechanical integrity improvements over monomeric collagens. The high
mechanical integrity allows the oligomeric collagen gels to withstand a forced removal of
a portion of the interstitial fluid phase, plastically creating materials with a much higher
collagen fibril density and increased material properties.
The densification technique created materials with controlled high level biophysical
properties, including order of magnitude increases in elastic and compressive moduli, as
well as increases in resistance to proteolytic degradation. The process was found to be
amenable to cell encapsulation, creating high density cellularized tissue constructs which
could impart controlled biomechanical cues to the encapsulated cells.
The densified collagen oligomer materials were capable of withstanding a
lyophilization procedure, and could be rehydrated without an effect on the mechanical or
biochemical properties of the collagen by utilizing an ethanol rehydrating solution.
The high-density collagen-fibril materials were found to have significantly higher elastic
and compressive mechanical properties than a commercial, crosslinked, fibrillar collagen
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sponge. The proteolytic degradation properties of the two materials were statistically
similar, quite interesting considering the high-density collagen-fibril material contains no
crosslinking to limit the biological activity of the collagen. Overall the high-density
collagen-fibril material shows excellent promise as a clinical tool for tissue engineering
applications.
Overall, the materials created for this study provide the controllable
microstructure and repeatability of polymerizable collagen, the natural biophysical
signaling properties and mechanical properties of decellularized tissue, and the long term
storage and ease of use of fibrillary collagen sponges, without the need for any
exogenous crosslinking.
4.2

Future Directions

The mechanical integrity differences between the monomeric and oligomeric
collagen formulations provide an outlook for further studies. In particular, a combination
of monomeric collagens and oligomeric collagens combined with the densification
technology explored here could create materials with high level collagen fibril densities
with a range of material properties. This research could add a further level of individual
property control for tissue engineering applications.
The increased collagen density provided by the densification allows for the creation
of cellularized in vitro tissue constructs for basic science studies. Because the cell-matrix
interactions have a drastic effect on cell proliferation and differentiation, creation of an in
vivo-like microstructure is paramount to an in vitro understanding of how cells behave in
vivo. This technique, densification of oligomer collagen matrices, could allow for studies
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of the effects of high collagen density microstructures on stem cell fate, or allow for the
creation of more bone-like microstructures for study. In addition, this technology could
allow for the creation of cryopreserved high density tissue constructs.
In order to further examine the clinical potential of the high-density collagen-fibril
materials, in vivo studies are necessary. Evaluating how the sponges fair in an in vivo
environment with further elucidate the effects the branched fibril network and high
collagen fibril density can have on wound healing.
In addition, the effect of sterilization on the high-density collagen-fibril materials is
necessary to evaluate how the biophysical properties change through this process. ETO
sterilization is the current industry gold standard for collagen based products, and has
been shown to have limited effects on the properties of the materials. So, it is likely that
ETO sterilization will be adequate for use on the high-density collagen-fibril materials
and will not cause destruction of the biophysical properties.
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